These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5033956)

  • 21. A randomized trial of cisplatin (CACP) + 5-fluorouracil (5-FU) infusion and CACP + 5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck.
    Kish JA; Ensley JF; Jacobs J; Weaver A; Cummings G; Al-Sarraf M
    Cancer; 1985 Dec; 56(12):2740-4. PubMed ID: 3902199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bleomycin (NSC-125066): phase I clinical study.
    Sonntag RW
    Cancer Chemother Rep; 1972 Apr; 56(2):197-205. PubMed ID: 4114485
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of refractory metastatic breast cancer with 5-fluorouracil and levofolinic acid as 48 hours continuous venous infusion.
    Gebbia V; Mauceri G; Testa A; Tirrito M; Varvara F; Cucchiara A; Borsellino N; Girlando A; Ferrara M; Caruso F
    Anticancer Res; 1999; 19(3B):2289-92. PubMed ID: 10472346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the combination of hexamethylmelamine (NSC-13875) and methotrexate (NSC-740) in carcinoma of the lung.
    Weiss AJ; Wilson WL
    Cancer Chemother Rep; 1971 Jun; 55(3):299-302. PubMed ID: 5115850
    [No Abstract]   [Full Text] [Related]  

  • 25. High-dose continuous infusion folinic acid and bolus 5-fluorouracil in patients with advanced colorectal cancer: a phase II study.
    Bertrand M; Doroshow JH; Multhauf P; Blayney DW; Carr BI; Cecchi G; Goldberg D; Leong L; Margolin K; Metter G
    J Clin Oncol; 1986 Jul; 4(7):1058-61. PubMed ID: 3487626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study.
    Windschitl H; Scott M; Schutt A; McCormack G; Everson L; Cullinan S; Gerstner J; Krook J; Laurie J; Shreck R
    Cancer Treat Rep; 1983 Nov; 67(11):1001-8. PubMed ID: 6640551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronomodulated chemotherapy with oxaliplatin, 5-FU and sodium folinate in metastatic gastrointestinal cancer patients: original analysis of non-hematological toxicity and patient characteristics in a pilot investigation.
    Farker K; Merkel U; Wedding U; Hippius M; Höffken K; Hoffmann A
    Int J Clin Pharmacol Ther; 2006 Jan; 44(1):31-7. PubMed ID: 16425969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative evaluation of the efficacy of fluorofur (Ftorafur) and 5-fluorouracil (5-ftouracil) in the treatment of breast cancer].
    Karev N; Blokhina N; Voznyi E; Perscin M
    Minerva Med; 1974 Jul; 65(52):2811-4. PubMed ID: 4846402
    [No Abstract]   [Full Text] [Related]  

  • 29. [A late phase II trial of l-leucovorin and 5-fluorouracil in advanced colorectal cancer. l-Leucovorin and 5-FU Study Group (Japan Western Group)].
    Konishi K; Yabushita K; Taguchi T; Ota J; Takashima S; Abe T; Kikkawa N; Yasutomi M; Sowa M; Maehara Y
    Gan To Kagaku Ryoho; 1995 Jun; 22(7):925-32. PubMed ID: 7793998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A phase I trial of dactinomycin intravenous infusion in patients with advanced malignancies.
    Blumenreich MS; Woodcock TM; Richman SP; Jones MK; Gentile PS; Kubota TT; Allegra JC
    Cancer; 1985 Jul; 56(2):256-8. PubMed ID: 4005796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Combination therapy with 5-fluorouracil (5-FU), cisplatin (CDDP) and interferon alpha-2B (IFN alpha-2B) for advanced renal cell carcinoma].
    Fujinami K; Ikeda I; Miura T; Kondo I
    Gan To Kagaku Ryoho; 1996 Oct; 23(12):1689-91. PubMed ID: 8886046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative Group.
    Feliu J; González Barón M; García-Girón C; Espinosa E; García-Alfonso P; Belón J; Blanco E; Garrido P; Ordónez A; Gómez-Navarro J; Zamora P
    Cancer; 1996 Jul; 78(2):211-6. PubMed ID: 8673994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of 5-fluorouracil on small bowel mucosa.
    White RS; Fuqua WB; Barrett O
    J Surg Oncol; 1971; 3(5):501-6. PubMed ID: 5114102
    [No Abstract]   [Full Text] [Related]  

  • 34. Investigation into the usefulness and adverse events of CDDP, 5-fU and dl-leucovorin (PFL-therapy) for advanced colorectal cancer.
    Okabe S; Ishikawa T; Tanami H; Kuwabara H; Fukahara T; Udagawa M; Ootsukasa S; Arai T; Maruyama S; Murase N; Yamashita H; Iwai T
    J Med Dent Sci; 2002 Jun; 49(2):77-84. PubMed ID: 12627817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allopurinol modulation of high-dose fluorouracil toxicity.
    Fox RM; Woods RL; Tattersall HN; Brodie GW
    Cancer Treat Rev; 1979 Jun; 6 Suppl():143-7. PubMed ID: 498168
    [No Abstract]   [Full Text] [Related]  

  • 36. Phase I clinical and pharmacokinetic study of protein kinase C-alpha antisense oligonucleotide ISIS 3521 administered in combination with 5-fluorouracil and leucovorin in patients with advanced cancer.
    Mani S; Rudin CM; Kunkel K; Holmlund JT; Geary RS; Kindler HL; Dorr FA; Ratain MJ
    Clin Cancer Res; 2002 Apr; 8(4):1042-8. PubMed ID: 11948111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activity of sequential low-dose methotrexate and fluorouracil in advanced colorectal carcinoma: attempt at correlation with tissue and blood levels of phosphoribosylpyrophosphate.
    Kemeny NE; Ahmed T; Michaelson RA; Harper HD; Yip LC
    J Clin Oncol; 1984 Apr; 2(4):311-5. PubMed ID: 6200577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitoxantrone, 5-fluorouracil and cyclophosphamide in advanced breast cancer.
    Martoni A; Rani P; Ercolino L; Canova N; Pannuti F
    Chemioterapia; 1988 Oct; 7(5):345-9. PubMed ID: 3224403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of 5-fluorouracil administered by slow infusion and rapid injection.
    Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
    Cancer Res; 1972 Dec; 32(12):2717-9. PubMed ID: 4566290
    [No Abstract]   [Full Text] [Related]  

  • 40. 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with gastrointestinal carcinoma.
    Moertel CG; Reitemeier RJ; Hahn RG; Schutt AJ
    Cancer Chemother Rep; 1970 Dec; 54(6):471-3. PubMed ID: 4946016
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.